SequelSEC

Medinotec Inc. MDNC

Surgical & Medical Instruments & Apparatus · CIK 0001931055 · Fiscal year ends 0228

AnnualQuarterlyTTM
Revenue
$9.73M
Fiscal year ended 2026-02-28
Operating income
$1.09M
Fiscal year ended 2026-02-28
Free cash flow
$905.44K
Fiscal year ended 2026-02-28

Medinotec Inc. (MDNC) reported revenue of $9.73M and net income of $794.50K for the fiscal year ended 2026-02-28. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from Medinotec Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Medinotec Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-282025-02-282024-02-292023-02-28
Revenue$9.73M$9.11M$5.02M$999.58K
Cost of revenue$4.60M$4.30MUnavailableUnavailable
Gross profit$5.13M$4.82MUnavailableUnavailable
Operating income$1.09M$3.19M$600.58K-$238.59K
Net income$794.50K$2.16M-$404.69K-$352.74K
Research & development$149.86K$91.13K-$22.35K-$64.87K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailable
Pretax income$1.07M$3.02M-$253.77K-$391.48K
Income tax expense-$274.68K-$864.66K-$150.92K$38.74K
Diluted EPSUnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$3.80M$1.46M-$1.76M-$701.99K
General & administrative$2.32M$1.35M-$1.67M-$648.17K
Selling & marketing$1.49M$113.19K-$84.56K-$53.82K

Balance

Medinotec Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-282025-02-282024-02-292023-02-28
Cash & equivalentsUnavailableUnavailableUnavailableUnavailable
Total assets$6.81M$6.81M$4.80M$4.49M
Current assets$6.42M$6.42M$4.38M$3.37M
Total liabilities$1.10M$2.54M$2.64M$1.93M
Current liabilities$1.10M$1.51M$827.45K$71.31K
Total equity incl. NCI$5.71M$4.27M$2.17M$2.56M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivable$2.35M$2.61M$589.76K$21.07K
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailable

Cash flow

Medinotec Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-282025-02-282024-02-292023-02-28
Operating cash flow$906.80K$877.83K$14.24K-$490.55K
Capital expenditures$1.36K$89.01K-$2.26K$55.28K
Investing cash flow-$1.36K-$89.01K$10.12K-$529.72K
Financing cash flow-$982.97K-$894.48K-$8.09K$3.58M
Net change in cash-$12.66K-$39.22K-$18.55K$2.70M
Stock-based compensationUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$80.87K$73.85K$88.22K$53.55K

Derived

Medinotec Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-282025-02-282024-02-292023-02-28
Free cash flow$905.44K$788.82KUnavailable-$545.83K
Gross margin52.7%52.9%48.7%58.2%
Operating margin11.2%35.0%12.0%-23.9%
FCF margin9.3%8.7%Unavailable-54.6%
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratio5.83x4.27x5.29x47.25x
Revenue YoY growth6.8%81.5%402.3%Unavailable
Net margin8.2%23.7%-8.1%-35.3%
R&D / revenue1.5%1.0%-0.4%-6.5%
CapEx / revenue0.0%1.0%-0.0%5.5%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rate-25.7%-28.6%UnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDNC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-09View SEC filing
10-K · Filed 2026-05-28View SEC filing
10-Q · Filed 2026-01-09View SEC filing
10-Q · Filed 2025-10-08View SEC filing
10-Q · Filed 2025-07-16View SEC filing
10-K · Filed 2025-05-29View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-02-29

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-02-28

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.